DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4fkjfc/renal_denervation) has announced the addition of the "Renal Denervation Market - Current Situation & Future Outlook" report to their offering.
Renal artery denervation, a new device-based therapeutic paradigm for managing treatment resistant hypertension, has come of age and is attracting an unprecedented gold rush from serial medical device entrepreneurs.
Medtronic's acquisition of Ardian for $800 million plus $500 million more in milestone payments in January 2011 signaled the dawning of a new era of catheter-based renal denervation systems.
Results of the Symplicity HTN-1 and Symplicity HTN-2 trials have generated considerable interest among physicians, patients, medical device entrepreneurs, and the investment community.
The market, although still in the inception phase, has already attracted heavy hitters with Covidien paying $230 Million for Maya Medical' OneShot renal denervation system, St. Jude launching its EnligHTN renal denervation system in Europe in May 2012 and Boston Scientific diverting its R&D resources for a first-in-man with a new device before the end of 2012.
Renal denervation is a catheter-based therapy that uses either radiofrequency or ultrasound energy to disrupt the renal arteries sympathetic nerves whose hyperactivity may lead to treatment-resistant hypertension.
Renal denervation systems are perhaps the hottest medical device innovation space this year as they offer a complementary approach to the management of resistant hypertension that was not available before.
Renal Denervation Market report attempts to answer some important questions regarding the fast evolving market by examining Leading companies technologies, product offerings, market shares. The report offers a credible forecast to 2016.
Companies Mentioned
- Ardian
- Boston Scientific
- CardioSonic
- Covidien
- Kona Medical
- Maya Medical
- Mercator MedSystems
- Medtronic
- ReCor Medical
- St. Jude Medical
- Vessix Vascular
For more information visit http://www.researchandmarkets.com/research/4fkjfc/renal_denervation